How Do Emerging Infectious Diseases Affect National Security and Policy Discussions?

Video

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future.

Amesh Adalja, MD, UPMC Center for National Security and his colleagues study recent outbreaks and work on how to better prepare the country for outbreaks like this in the future. At IDWeek 2016, Adalja explained that his team looked at non-traditional approaches as in rather scrutinizing ordinary antibiotics when you have ore and more resistance, he was "thinking about changing the whole game and going into more specific targeted therapies". He wanted to look at what's the case for bacterial phages, and question how would one facilitate the use of those in clinical settings. "We're taking what's going on in the scientific world and bridging it into the clinical and policy worlds," said Adalja.

Related Videos
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
Matthew Nudy, MD | Credit: Penn State Health
© 2024 MJH Life Sciences

All rights reserved.